# NPS PHARMACEUTICALS INC

NPS PHARMACEUTICALS INC is a company headquartered in Bedminster, NJ, United States.

## Company overview

- **Legal name:** NPS PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Bedminster, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000890465

## About

NPS PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000890465, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2015-02-18, it reported annual revenue of USD 224,062,000; net income of USD -8,705,000; total assets of USD 289,617,000 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $224.1M (USD 224,062,000)
- **Net income:** -$8.7M (USD -8,705,000)
- **Total assets:** $289.6M (USD 289,617,000)
- **Cash and equivalents:** $65.6M (USD 65,565,000)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $155.6M (USD 155,592,000)
- **Net income:** -$13.5M (USD -13,504,000)
- **Total assets:** $292.2M (USD 292,222,000)
- **Cash and equivalents:** $51.2M (USD 51,204,000)
- **Operating cash flow:** -$24.3M (USD -24,316,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $130.6M (USD 130,644,000)
- **Net income:** -$18.7M (USD -18,735,000)
- **Total assets:** $151.1M (USD 151,109,000)
- **Cash and equivalents:** $17.5M (USD 17,471,000)
- **Operating cash flow:** -$61.0M (USD -60,992,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $101.6M (USD 101,645,000)
- **Total assets:** $214.0M (USD 213,980,000)
- **Cash and equivalents:** $82.4M (USD 82,401,000)
- **Operating cash flow:** -$56.7M (USD -56,658,000)

## Recent SEC filings

- Form 8-K — filed 2015-02-23 — period 2015-02-20 — 8-K
- Form 10-K/A — filed 2015-02-23 — period 2014-12-31 — 10-K/A
- Form 10-K — filed 2015-02-18 — period 2014-12-31 — 10-K
- Form SC 13G — filed 2015-02-10
- Form 8-K — filed 2015-01-12 — period 2015-01-11 — 8-K
- Form 10-Q — filed 2014-11-10 — period 2014-09-30 — 10-Q
- Form 8-K — filed 2014-11-10 — period 2014-11-10 — NPS PHARMACEUTICALS, INC. 8-K
- Form 8-K — filed 2014-11-04 — period 2014-11-03 — NPS PHARMACEUTICALS, INC. 8-K
- Form 8-K — filed 2014-09-12 — period 2014-09-12 — NPS PHARMACEUTICALS, INC. 8-K
- Form 10-Q — filed 2014-08-06 — period 2014-06-30 — 10-Q
- Form 8-K — filed 2014-08-06 — period 2014-08-06 — NPS PHARMACEUTICALS, INC. 8-K
- Form 8-K — filed 2014-06-10 — period 2014-06-10 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/nps-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology